GERN
Geron Corporation
Price Chart
Latest Quote
$1.35
+0.01 (+0.75%)
Current Price
| Previous Close | $1.34 |
| Open | $1.32 |
| Day High | $1.36 |
| Day Low | $1.29 |
| Volume | 12,868,279 |
Stock Information
| Shares Outstanding | 641.52M |
| Total Debt | $122.07M |
| Cash Equivalents | $312.40M |
| Revenue | $196.12M |
| Net Income | $-67.31M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $866.05M |
| EPS (TTM) | $-0.11 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $675.72M |
| Sales | $196.12M |
| Income | $-67.31M |
| Book/sh | $0.36 |
| Cash/sh | $0.49 |
| Employees | 258 |
Financial Ratios
| Quick Ratio | 4.85 |
| Current Ratio | 6.78 |
| Debt/Eq | 53.28 |
Returns & Margins
| ROA | -4.00% |
| ROE | -27.07% |
| Gross Margin | 60.97% |
| Operating Margin | -0.46% |
| Profit Margin | -34.32% |
Ownership
| Insider Ownership | 0.08% |
| Institutional Ownership | 79.53% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 20.77 |
| P/S | 4.42 |
| P/B | 3.78 |
Analyst Data
| Recommendation | none |
| Target Price | $3.40 |
Technical Indicators
| SMA20 | $1.21 |
| SMA50 | $1.37 |
| SMA200 | $1.39 |
| RSI | 71.43 |
| ATR | 0.0721 |
| Shares Float | 535.71M |
| Short Float | 11.20% |
| Short Ratio | 5.04 |
| Volatility | 0.60 |
| Rel Volume | 0.99 |
Performance History
| Week | +17.39% |
| Month | +7.14% |
| Quarter | -12.34% |
| 6 Months | +0.75% |
| YTD | +2.27% |
| Year | -10.60% |
| 3 Years | -55.45% |
| 5 Years | -2.88% |
| 10 Years | -47.88% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $1.35 | 12,868,279 |
| 2026-06-22 | $1.34 | 18,713,500 |
| 2026-06-18 | $1.26 | 22,995,900 |
| 2026-06-17 | $1.23 | 13,869,400 |
| 2026-06-16 | $1.18 | 10,258,700 |
| 2026-06-15 | $1.15 | 9,845,000 |
| 2026-06-12 | $1.15 | 8,110,300 |
| 2026-06-11 | $1.14 | 31,746,000 |
| 2026-06-10 | $1.10 | 14,737,300 |
| 2026-06-09 | $1.12 | 13,609,100 |
| 2026-06-08 | $1.13 | 11,184,600 |
| 2026-06-05 | $1.17 | 9,600,800 |
| 2026-06-04 | $1.21 | 9,830,700 |
| 2026-06-03 | $1.16 | 10,092,800 |
| 2026-06-02 | $1.17 | 13,031,800 |
| 2026-06-01 | $1.21 | 8,361,100 |
| 2026-05-29 | $1.25 | 11,694,400 |
| 2026-05-28 | $1.25 | 10,148,300 |
| 2026-05-27 | $1.26 | 8,284,500 |
| 2026-05-26 | $1.28 | 10,873,300 |
About Geron Corporation
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.
đ° Latest News
After Plunging 26.6% in 4 Weeks, Here's Why the Trend Might Reverse for Geron (GERN)
Zacks âĸ 2026-06-04T13:35:02Z
Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks âĸ 2026-05-19T13:35:02Z
Is Geron (GERN) One of the Best US Stocks Under $5 to Buy?
Insider Monkey âĸ 2026-05-11T21:21:25Z
A Look At Geron (GERN) Valuation After Q1 Results And Reaffirmed 2026 Guidance
Simply Wall St. âĸ 2026-05-08T13:17:52Z
Geron Corporation (NASDAQ:GERN) Just Reported And Analysts Have Been Lifting Their Price Targets
Simply Wall St. âĸ 2026-05-08T13:02:21Z
Geron Corporation Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T12:30:00Z
Geron Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-06T13:07:52Z
Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-06T12:25:04Z
Geron Corporation (GERN) Appoints Timothy Williams as EVP, Chief Legal Officer
Insider Monkey âĸ 2026-04-25T21:06:26Z
Geron Adds Chief Legal Officer As Equity Ties To Execution Risk
Simply Wall St. âĸ 2026-04-15T00:14:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $4,745,000 | $1,256,000 | $0 | $0 |
| Cost Of Revenue | $4,745,000 | $1,256,000 | $0 | $0 |
| Total Revenue | $183,881,000 | $76,994,000 | $237,000 | $596,000 |
| Operating Revenue | $223,370,000 | $89,917,000 | $237,000 | $596,000 |
| Expenses | ||||
| Interest Expense | $32,657,000 | $18,504,000 | $8,312,000 | $6,882,000 |
| Total Expenses | $235,434,000 | $250,726,000 | $194,181,000 | $139,146,000 |
| Other Income Expense | $-17,407,000 | $-1,943,000 | $-23,000 | $1,002,000 |
| Other Non Operating Income Expenses | $-375,000 | $-236,000 | $-23,000 | $1,002,000 |
| Net Non Operating Interest Income Expense | $-14,540,000 | $1,103,000 | $9,840,000 | $-4,353,000 |
| Interest Expense Non Operating | $32,657,000 | $18,504,000 | $8,312,000 | $6,882,000 |
| Operating Expense | $230,689,000 | $249,470,000 | $194,181,000 | $139,146,000 |
| General And Administrative Expense | - | $145,732,000 | $69,135,000 | $43,628,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-83,500,000 | $-174,572,000 | $-184,127,000 | $-141,901,000 |
| Net Interest Income | $-14,540,000 | $1,103,000 | $9,840,000 | $-4,353,000 |
| Interest Income | $18,117,000 | $19,607,000 | $18,152,000 | $2,529,000 |
| Normalized Income | $-66,485,032 | $-172,870,121 | $-184,127,000 | $-141,901,000 |
| Net Income From Continuing And Discontinued Operation | $-83,500,000 | $-174,572,000 | $-184,127,000 | $-141,901,000 |
| Total Operating Income As Reported | $-68,585,000 | $-173,732,000 | $-193,944,000 | $-138,550,000 |
| Net Income Common Stockholders | $-83,500,000 | $-174,572,000 | $-184,127,000 | $-141,901,000 |
| Net Income | $-83,500,000 | $-174,572,000 | $-184,127,000 | $-141,901,000 |
| Net Income Including Noncontrolling Interests | $-83,500,000 | $-174,572,000 | $-184,127,000 | $-141,901,000 |
| Net Income Continuous Operations | $-83,500,000 | $-174,572,000 | $-184,127,000 | $-141,901,000 |
| Pretax Income | $-83,500,000 | $-174,572,000 | $-184,127,000 | $-141,901,000 |
| Special Income Charges | $-17,032,000 | $-1,707,000 | $0 | $0 |
| Interest Income Non Operating | $18,117,000 | $19,607,000 | $18,152,000 | $2,529,000 |
| Operating Income | $-51,553,000 | $-173,732,000 | $-193,944,000 | $-138,550,000 |
| Gross Profit | $179,136,000 | $75,738,000 | $237,000 | $596,000 |
| Per Share | ||||
| Diluted EPS | $-0.13 | $-0.27 | $-0.32 | $-0.37 |
| Basic EPS | $-0.13 | $-0.27 | $-0.32 | $-0.37 |
| Other | ||||
| Tax Effect Of Unusual Items | $-17,032 | $-5,121 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-32,607,000 | $-153,140,000 | $-174,782,000 | $-134,151,000 |
| Total Unusual Items | $-17,032,000 | $-1,707,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-17,032,000 | $-1,707,000 | $0 | $0 |
| Reconciled Depreciation | $1,204,000 | $1,221,000 | $1,033,000 | $868,000 |
| EBITDA (Bullshit earnings) | $-49,639,000 | $-154,847,000 | $-174,782,000 | $-134,151,000 |
| EBIT | $-50,843,000 | $-156,068,000 | $-175,815,000 | $-135,019,000 |
| Diluted Average Shares | $666,662,989 | $646,033,247 | $570,645,405 | $380,784,846 |
| Basic Average Shares | $666,662,989 | $646,033,247 | $570,645,405 | $380,784,846 |
| Diluted NI Availto Com Stockholders | $-83,500,000 | $-174,572,000 | $-184,127,000 | $-141,901,000 |
| Restructuring And Mergern Acquisition | $17,032,000 | $0 | $0 | - |
| Research And Development | $71,433,000 | $103,738,000 | $125,046,000 | $95,518,000 |
| Selling General And Administration | $159,256,000 | $145,732,000 | $69,135,000 | $43,628,000 |
| Other Special Charges | - | $1,707,000 | - | - |
| Other Gand A | - | $145,732,000 | $69,135,000 | $43,628,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $225,872,000 | $280,320,000 | $247,949,000 | $79,998,000 |
| Total Assets | $570,540,000 | $593,781,000 | $394,076,000 | $190,575,000 |
| Total Non Current Assets | $50,269,000 | $102,789,000 | $52,728,000 | $10,329,000 |
| Other Non Current Assets | $5,945,000 | $4,079,000 | $4,697,000 | $5,389,000 |
| Investmentin Financial Assets | $41,289,000 | $94,519,000 | $43,298,000 | $0 |
| Current Assets | $520,271,000 | $490,992,000 | $341,348,000 | $180,246,000 |
| Other Current Assets | $4,610,000 | $5,053,000 | $4,879,000 | $3,992,000 |
| Restricted Cash | $1,880,000 | $1,860,000 | $1,115,000 | $364,000 |
| Inventory | $116,636,000 | $38,714,000 | $0 | - |
| Receivables | $39,226,000 | $38,799,000 | $1,655,000 | $3,144,000 |
| Accrued Interest Receivable | $2,239,000 | $2,853,000 | $1,655,000 | $3,144,000 |
| Accounts Receivable | $36,987,000 | $35,946,000 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $357,919,000 | $406,566,000 | $333,699,000 | $172,746,000 |
| Cash And Cash Equivalents | $77,560,000 | $79,016,000 | $70,023,000 | $56,845,000 |
| Non Current Prepaid Assets | - | - | - | $5,389,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $41,987,000 | $39,460,000 | $11,921,000 | - |
| Total Debt | $121,992,000 | $121,716,000 | $85,899,000 | $55,753,000 |
| Long Term Debt And Capital Lease Obligation | $120,992,000 | $120,742,000 | $38,057,000 | $33,883,000 |
| Long Term Debt | $119,547,000 | $118,476,000 | $35,051,000 | $30,212,000 |
| Current Debt And Capital Lease Obligation | $1,000,000 | $974,000 | $47,842,000 | $21,870,000 |
| Current Debt | - | - | $46,893,000 | $20,945,000 |
| Other Current Borrowings | - | - | $46,893,000 | $20,945,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $344,668,000 | $313,461,000 | $146,127,000 | $110,577,000 |
| Total Non Current Liabilities Net Minority Interest | $233,126,000 | $225,163,000 | $38,057,000 | $33,883,000 |
| Other Non Current Liabilities | $112,134,000 | $104,421,000 | - | - |
| Current Liabilities | $111,542,000 | $88,298,000 | $108,070,000 | $76,694,000 |
| Other Current Liabilities | $17,448,000 | $20,372,000 | - | - |
| Current Deferred Liabilities | $3,486,000 | $1,038,000 | - | - |
| Payables And Accrued Expenses | $59,111,000 | $43,106,000 | $46,469,000 | $43,290,000 |
| Interest Payable | $3,110,000 | $2,186,000 | $768,000 | $561,000 |
| Payables | $11,257,000 | $8,595,000 | $6,161,000 | $10,190,000 |
| Accounts Payable | $11,257,000 | $8,595,000 | $6,161,000 | $10,190,000 |
| Equity | ||||
| Common Stock Equity | $225,872,000 | $280,320,000 | $247,949,000 | $79,998,000 |
| Total Equity Gross Minority Interest | $225,872,000 | $280,320,000 | $247,949,000 | $79,998,000 |
| Stockholders Equity | $225,872,000 | $280,320,000 | $247,949,000 | $79,998,000 |
| Gains Losses Not Affecting Retained Earnings | $269,000 | $261,000 | $185,000 | $-219,000 |
| Other Equity Adjustments | $269,000 | $261,000 | $185,000 | $-219,000 |
| Retained Earnings | $-1,855,841,000 | $-1,772,341,000 | $-1,597,769,000 | $-1,413,642,000 |
| Other | ||||
| Ordinary Shares Number | $639,856,222 | $606,387,666 | $544,912,215 | $390,262,524 |
| Share Issued | $639,856,222 | $606,387,666 | $544,912,215 | $390,262,524 |
| Tangible Book Value | $225,872,000 | $280,320,000 | $247,949,000 | $79,998,000 |
| Invested Capital | $345,419,000 | $398,796,000 | $329,893,000 | $131,155,000 |
| Working Capital | $408,729,000 | $402,694,000 | $233,278,000 | $103,552,000 |
| Capital Lease Obligations | $2,445,000 | $3,240,000 | $3,955,000 | $4,596,000 |
| Total Capitalization | $345,419,000 | $398,796,000 | $283,000,000 | $110,210,000 |
| Additional Paid In Capital | $2,080,804,000 | $2,051,794,000 | $1,844,988,000 | $1,493,469,000 |
| Capital Stock | $640,000 | $606,000 | $545,000 | $390,000 |
| Common Stock | $640,000 | $606,000 | $545,000 | $390,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $1,445,000 | $2,266,000 | $3,006,000 | $3,671,000 |
| Current Deferred Revenue | $3,486,000 | $1,038,000 | - | - |
| Current Capital Lease Obligation | $1,000,000 | $974,000 | $949,000 | $925,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $30,497,000 | $22,808,000 | $13,759,000 | $11,534,000 |
| Current Accrued Expenses | $47,854,000 | $34,511,000 | $40,308,000 | $33,100,000 |
| Investments And Advances | $41,289,000 | $94,519,000 | $43,298,000 | $0 |
| Held To Maturity Securities | $41,289,000 | $94,519,000 | - | - |
| Net PPE | $3,035,000 | $4,191,000 | $4,733,000 | $4,940,000 |
| Accumulated Depreciation | $-2,204,000 | $-1,697,000 | $-1,231,000 | $-896,000 |
| Gross PPE | $5,239,000 | $5,888,000 | $5,964,000 | $5,836,000 |
| Leases | $129,000 | $129,000 | $135,000 | $135,000 |
| Machinery Furniture Equipment | $2,959,000 | $2,878,000 | $2,273,000 | $1,554,000 |
| Buildings And Improvements | $2,151,000 | $2,881,000 | $3,556,000 | $4,147,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $15,740,000 | $3,717,000 | $0 | - |
| Work In Process | $91,969,000 | $30,093,000 | - | - |
| Raw Materials | $8,927,000 | $4,904,000 | - | - |
| Other Short Term Investments | $280,359,000 | $327,550,000 | $263,676,000 | $115,901,000 |
| Available For Sale Securities | - | $94,519,000 | $43,298,000 | - |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-111,086,000 | $-219,298,000 | $-168,573,000 | $-127,810,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-111,037,000 | $-218,618,000 | $-167,743,000 | $-127,379,000 |
| Cash Flow From Continuing Operating Activities | $-111,037,000 | $-218,618,000 | $-167,743,000 | $-127,379,000 |
| Operating Gains Losses | - | $1,707,000 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-49,000 | $-680,000 | $-830,000 | $-431,000 |
| Investing Cash Flow | $107,247,000 | $-106,004,000 | $-180,322,000 | $62,067,000 |
| Cash Flow From Continuing Investing Activities | $107,247,000 | $-106,004,000 | $-180,322,000 | $62,067,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $140,729,000 | $213,337,000 | $69,916,000 |
| Financing Cash Flow | $2,267,000 | $334,372,000 | $362,021,000 | $87,264,000 |
| Cash Flow From Continuing Financing Activities | $2,267,000 | $334,372,000 | $362,021,000 | $87,264,000 |
| Net Common Stock Issuance | $0 | $140,729,000 | $213,337,000 | $69,916,000 |
| Common Stock Issuance | $0 | $140,729,000 | $213,337,000 | $69,916,000 |
| Net Other Financing Charges | - | $125,000,000 | - | - |
| Other | ||||
| Repayment Of Debt | $0 | $-86,554,000 | $0 | $0 |
| Issuance Of Debt | $0 | $121,120,000 | $29,700,000 | $0 |
| End Cash Position | $79,440,000 | $80,876,000 | $71,138,000 | $57,209,000 |
| Beginning Cash Position | $80,876,000 | $71,138,000 | $57,209,000 | $35,235,000 |
| Effect Of Exchange Rate Changes | $87,000 | $-12,000 | $-27,000 | $22,000 |
| Changes In Cash | $-1,523,000 | $9,750,000 | $13,956,000 | $21,952,000 |
| Proceeds From Stock Option Exercised | $2,267,000 | $34,077,000 | $118,984,000 | $17,348,000 |
| Net Issuance Payments Of Debt | $0 | $34,566,000 | $29,700,000 | $0 |
| Net Long Term Debt Issuance | $0 | $34,566,000 | $29,700,000 | $0 |
| Long Term Debt Payments | $0 | $-86,554,000 | $0 | $0 |
| Long Term Debt Issuance | $0 | $121,120,000 | $29,700,000 | $0 |
| Net Investment Purchase And Sale | $107,296,000 | $-105,324,000 | $-179,492,000 | $62,498,000 |
| Sale Of Investment | $411,717,000 | $371,608,000 | $296,102,000 | $320,505,000 |
| Purchase Of Investment | $-304,421,000 | $-476,932,000 | $-475,594,000 | $-258,007,000 |
| Net PPE Purchase And Sale | $-49,000 | $-680,000 | $-830,000 | $-431,000 |
| Purchase Of PPE | $-49,000 | $-680,000 | $-830,000 | $-431,000 |
| Change In Working Capital | $-68,536,000 | $-70,597,000 | $6,059,000 | $5,027,000 |
| Change In Other Working Capital | $7,689,000 | $9,049,000 | $2,224,000 | $3,435,000 |
| Change In Other Current Liabilities | $-14,955,000 | $-2,901,000 | $-640,000 | $-572,000 |
| Change In Payables And Accrued Expense | $18,451,000 | $-2,324,000 | $3,179,000 | $6,769,000 |
| Change In Accrued Expense | $15,790,000 | $-4,759,000 | $7,208,000 | $3,266,000 |
| Change In Payable | $2,661,000 | $2,435,000 | $-4,029,000 | $3,503,000 |
| Change In Account Payable | $2,661,000 | $2,435,000 | $-4,029,000 | $3,503,000 |
| Change In Prepaid Assets | $-1,422,000 | $443,000 | $-194,000 | $-3,224,000 |
| Change In Inventory | $-77,922,000 | $-37,971,000 | $0 | $0 |
| Change In Receivables | $-377,000 | $-36,893,000 | $1,490,000 | $-1,381,000 |
| Changes In Account Receivables | $-991,000 | $-35,695,000 | $0 | $0 |
| Other Non Cash Items | $20,019,000 | $2,237,000 | $1,088,000 | $1,327,000 |
| Stock Based Compensation | $26,747,000 | $31,320,000 | $19,354,000 | $8,265,000 |
| Provisionand Write Offof Assets | $-50,000 | $-251,000 | $0 | $0 |
| Amortization Of Securities | $-6,921,000 | $-9,683,000 | $-11,150,000 | $-965,000 |
| Depreciation Amortization Depletion | $1,204,000 | $1,221,000 | $1,033,000 | $868,000 |
| Depreciation And Amortization | $1,204,000 | $1,221,000 | $1,033,000 | $868,000 |
| Depreciation | $1,204,000 | $1,221,000 | $1,033,000 | $868,000 |
| Net Income From Continuing Operations | $-83,500,000 | $-174,572,000 | $-184,127,000 | $-141,901,000 |
| Pension And Employee Benefit Expense | - | $5,345,000 | $0 | $0 |
| Unrealized Gain Loss On Investment Securities | - | - | - | $0 |
| Net Business Purchase And Sale | - | - | - | - |
| Sale Of Business | - | - | - | - |
| Earnings Losses From Equity Investments | - | - | - | - |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-06-20